688131 皓元医药
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额77,065317,749381,960(63,606)(240,233)
投资活动产生之现金流量净额(88,931)(202,043)(783,654)(328,511)(713,002)
筹资活动产生之现金流量净额117,416177,002791,479409,209360,324
汇率变动对现金及现金等价物的影响(49,105)(1,084)7,8453,11114,415
现金及现金等价物净增加/(减少)56,445291,624397,63020,202(578,496)
期初现金及现金等价物余额1,164,720873,096475,466455,2641,033,760
期末现金及现金等价物余额1,221,1651,164,720873,096475,466455,264